Hardman & Co: Nearing first proprietary product
February 26 2018 - 5:31AM
ADVFN NewsWire
Hardman
& Co Res: Nearing first proprietary product
Closing in on first proprietary
product: Collagen
Solutions (COS) is a biomaterials company developing and
manufacturing medical grade collagen components for use in
medical devices, research and regenerative medicine. A number of
investment initiatives have been introduced to accelerate the rate
of growth, including global commercial infrastructure and
development of a pipeline of finished medical devices, the first of
which will be ChondroMimetic for repair of small cartilage lesions.
Eight years after implantation, clinical outcomes with
ChondroMimetic were at least as good as could be expected, and
better than those published in the literature for alternative
methods of cartilage repair.
Please click here for the full report:
http://hardmanandco.com/docs/default-source/company-docs/collagen-solutions-plc-documents/26.02.18-closing-in-on-first-proprietary-product.pdf
About Hardman & Co: For the past 21 years
Hardman has been producing specialist research designed to improve
investors' understanding of companies, sectors, industries and
investment securities. Our analysts are highly experienced in their
sectors, and have often been highly rated by professional investors
for their knowledge. Our focus is to raise companies' profiles
across the UK and abroad with outstanding research, investor
engagement programmes and advisory services. Some of our notes have
been commissioned by the company which is the subject of the note;
this is clearly stated in the disclaimer where this is the
case.
Hardman Research Ltd, trading as Hardman & Co, is an
appointed representative of Capital Markets Strategy Ltd and is
authorised and regulated by the Financial Conduct Authority; our
FCA registration number is 600843. Hardman Research Ltd is
registered at Companies House with number 8256259.
Our research is provided for the use of the professional
investment community, market counterparties and sophisticated and
high net worth investors as defined in the rules of the regulatory
bodies. It is not intended to be made available to unsophisticated
retail investors. Anyone who is unsure of their categorisation
should consult their professional advisors. This research is
neither an offer, nor a solicitation, to buy or sell any security.
Please read the note for the full disclaimer.
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2023 to Apr 2024